Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Devin Steenkamp MD

Devin W. Steenkamp MD

Director of Clinical Diabetes, Section of Endocrinology, Diabetes and Nutrition; Assistant Professor of Medicine, Boston University Chobanian and Avedisian School of Medicine and Boston Medical Center, Boston, Massachusetts

Devin Steenkamp is an endocrinologist with a particular interest in type 1 diabetes and atypical diabetes phenotypes such as monogenic diabetes. He is the Director of the Clinical Diabetes Program in the Section of Endocrinology, Diabetes and Nutrition at Boston Medical Center/Chobanian and Avedisian School of Medicine and his clinical practice and research interests are focused on the application of diabetes technologies in care.

Disclosures

Dr. Steenkamp reports the following:

  • Research support paid to institution: Abbott Diabetes Care, MannKind, Tandem Diabetes Care, Novo Nordisk
  • Consultant: Abbott Diabetes Care

Recent Contributions to PracticeUpdate:

  1. CGM Alarms in Adults With Type 1 Diabetes